"
Team:SupBiotech-Paris/Acknowledgement
From 2009.igem.org
(Difference between revisions)
Enguerrand (Talk | contribs) (→Our scientific) |
Enguerrand (Talk | contribs) |
||
| Line 20: | Line 20: | ||
:* Dr. Nicolas Veziris | :* Dr. Nicolas Veziris | ||
| + | |||
| + | <span style="float: right">[[Team:SupBiotech-Paris/Acknowledgement#drapeau|Back to top]]</span> | ||
==Our Sponsors== | ==Our Sponsors== | ||
Revision as of 15:51, 29 September 2009
Project
Introduction Current therapies Gene therapies DVS Concept Tissue Vector Cell Vector Therapeutic plasmid Conclusion Implementation Tissue targeting Antitumor action Treatment modeling Conclusion
Ressources
BioBricks Material & Method Bibliography
Ethics & Safety
Contents |
Our scientific consultants
UMR CNRS 8121 from the Gustave Roussy Institute
- Dr. Lluis M. Mir
- Dr. Karim Benihoud
INSERM U872
- Dr. Srinivas Kaveri
AnyGenes
- Dr. Benyoussef Naimi
National Reference Center for Mycobacteria and the Resistance of Mycobacteria to Antituberculosis from CHU Pitié-Salpêtrière
- Dr. Nicolas Veziris
Our Sponsors
